Emily Ko, MD, MSCR is a member of the Innovation Faculty at PC3I. Her work focuses on population science-based research studies, clinical trials, and health policy as it applies to gynecologic cancer care. Her primary areas of interest include uterine cancer and cervical cancer, specifically regarding cancer outcomes, access, costs of care and reimbursement.

Dr. Ko is a gynecologic oncologist, with a clinical practice within the University of Pennsylvania Health Systems. She is an Assistant Professor in the department of Obstetrics and Gynecology, Division of Gynecologic Oncology. As a physician-scientist, she provides surgical and medical-oncologic treatments for women with gynecologic cancers, pre-malignant conditions, and complex benign gynecologic conditions. Dr. Ko has received research funding from institutional as well as national organizations, including the American Society of Clinical Oncologists Conquer Cancer Foundation and the Gynecologic Oncology Group. At Penn, Dr. Ko is a full member of the Abramson Cancer Center Division of Clinical Cancer Control, and a Senior Scholar of the Penn Leonard Davis Institute of Health Economics. She also directs the Penn Gynecologic Oncology Population Science Research Group, and mentors multiple trainees through the Perelman School of Medicine Master’s in Science in Clinical Epidemiology (MSCE), and Master’s in Science in Health Policy Research (MSHP) programs. Together, her clinical practice, research efforts, and national service commitments focus on improving gynecologic cancer care. By utilizing multiple local, regional,and national cancer registries, administrative claims data, and clinical data sources, she seeks to develop strategies to define, evaluate, and improve the value of gynecologic cancer care.